What are the psychiatric side effects reported for singulair?

Side Effects of Singulair: Psychiatric Concerns

Singulair, also known as montelukast, is a medication primarily used to treat asthma and allergies. While generally considered safe, Singulair can cause psychiatric side effects in some individuals.

Mental Health Risks Associated with Singulair

[1] According to the Food and Drug Administration (FDA), Singulair has been linked to a higher risk of behavioral side effects, including suicidal thoughts, depression, and anxiety.

Psychiatric Symptoms Reported by Singulair Users

Common psychiatric side effects reported by Singulair users include:

* Anxiety
* Depression
* Suicidal thoughts
* Mood swings
* Insomnia
* Irritability

What You Need to Know About Singulair's Psychiatric Side Effects

Singulair's label has been updated to include a warning about the increased risk of psychiatric side effects. The FDA requires that all patients, especially those under the age of 16, be closely monitored for any signs of psychiatric problems while taking Singulair.

Monitoring and Alternatives

If you're taking Singulair and experience any psychiatric side effects, it's essential to consult with your doctor. They may recommend:

* Monitoring your symptoms
* Adjusting your medication dose
* Switching to a different medication

Biosimilars and Generic Options

[2] In 2020, the US Patent Exclusivity for Singulair expired, allowing generic versions of the medication to become available. These generic options may have a lower cost but may also have similar side effect profiles.

References:

[1] Food and Drug Administration. (2011). FDA Announces Safety Labeling Changes for Montelukast (Singulair) Tablets.

[2] DrugPatentWatch.com. (2020). Montelukast (Singulair) Patent Expiration.

Sources:

1. Food and Drug Administration (FDA) - https://www.fda.gov/
2. DrugPatentWatch.com - https://drugpatentwatch.com/